The main market opportunities in the RSV prophylaxis field lie in the development of new monoclonal antibodies and vaccines, with substantial growth expected due to late-stage pipeline products. This ...

If RSV develops into a more serious infection such as pneumonia or bronchiolitis, it may also cause a worsening cough, ...

Rollout of Scottish RSV vaccine programme among 75-79-year-olds showed marked drop in virus-related hospitalisations last ...

Antar stressed that “what remains of the coronavirus is merely scattered, non-impactful droplets, and no variant of the ...

UK Health Security Agency data show flu infections, hospitalisations and intensive care admissions all increased again last ...

Based on reports from doctors participating in the surveillance service, it is estimated that 185,900 people visited a doctor ...

On Thursday 27 November 2025, the Health Directorate of Luxembourg's Ministry of Health and Social Security published its ...

A new study published in the journal of Arthritis & Rheumatology revealed that patients with rheumatoid arthritis-associated ...

BRITS are being urged to look out for symptoms of RSV after an increase in cases of the highly contagious disease. The virus ...

People aged 75 to 79, as well as people who turned 80 after 1 September 2024, are eligible for a vaccine to protect against respiratory syncytial virus (RSV). RSV affects the airways and lungs and can ...